In the current study, we reasoned that MET sensitized the effects of BBR on controlling NSCLC cell growth through enhancing the inhibition of PDPK1, SP1 and DNMT1 expressions, or vice versa. Here, PDPK1 is linked to non-small cell lung carcinoma.